Bill Text: TX HB3146 | 2011-2012 | 82nd Legislature | Engrossed
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Relating to consent for treatment for chemical dependency in a treatment facility and required training for the facility's intake personnel.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Passed) 2011-06-17 - Effective on 9/1/11 [HB3146 Detail]
Download: Texas-2011-HB3146-Engrossed.html
Bill Title: Relating to consent for treatment for chemical dependency in a treatment facility and required training for the facility's intake personnel.
Spectrum: Partisan Bill (Democrat 2-0)
Status: (Passed) 2011-06-17 - Effective on 9/1/11 [HB3146 Detail]
Download: Texas-2011-HB3146-Engrossed.html
82R22836 AJZ-D | ||
By: Naishtat | H.B. No. 3146 |
|
||
|
||
relating to consent for treatment for chemical dependency in a | ||
treatment facility and required training for the facility's intake | ||
personnel. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Sections 462.009(e) and (g), Health and Safety | ||
Code, are amended to read as follows: | ||
(e) Consent given by a patient or by a person authorized by | ||
law to consent to treatment on the patient's behalf for the | ||
administration of a medication, therapy, or treatment is valid only | ||
if: | ||
(1) for consent to therapy or treatment: | ||
(A) the consent is given voluntarily and without | ||
coercive or undue influence; and | ||
(B) [ |
||
[ |
||
the psychologist, social worker, professional counselor, or | ||
chemical dependency counselor explains to the patient and to the | ||
person giving consent, in simple, nontechnical language: | ||
(i) [ |
||
treated; | ||
(ii) [ |
||
condition expected from the [ |
||
(iii) [ |
||
health consequences of not consenting to the [ |
||
therapy[ |
||
(iv) [ |
||
associated with the [ |
||
(v) [ |
||
alternatives to the [ |
||
and whether an alternative might be appropriate for the patient; | ||
and | ||
(vi) [ |
||
[ |
||
(2) for consent to the administration of medication: | ||
(A) the consent is given voluntarily and without | ||
coercive or undue influence; and | ||
(B) the treating physician provides each | ||
explanation required by Subdivision (1)(B) to the patient and to | ||
the person giving consent in simple, nontechnical language; and | ||
(3) for consent to medication, therapy, or treatment, | ||
the informed consent is evidenced in the patient's clinical record | ||
by a signed form prescribed by the commission for this purpose or by | ||
a statement of the treating physician or the psychologist, social | ||
worker, professional counselor, or chemical dependency counselor | ||
who obtained the consent that documents that consent was given by | ||
the appropriate person and the circumstances under which the | ||
consent was obtained. | ||
(g) Consent given by a patient or by a person authorized by | ||
law to consent to treatment on the patient's behalf applies to a | ||
series of doses of medication or to multiple therapies or | ||
treatments for which consent was previously granted. If the | ||
treating physician or the psychologist, social worker, | ||
professional counselor, or chemical dependency counselor obtains | ||
new information relating to a [ |
||
for which consent was previously obtained, the physician or the | ||
psychologist, social worker, professional counselor, or chemical | ||
dependency counselor must explain the new information and obtain | ||
new consent. If the treating physician obtains new information | ||
relating to a medication for which consent was previously obtained, | ||
the physician must explain the new information and obtain new | ||
consent. | ||
SECTION 2. The heading to Section 462.025, Health and | ||
Safety Code, is amended to read as follows: | ||
Sec. 462.025. INTAKE, SCREENING, ASSESSMENT, AND | ||
ADMISSION. | ||
SECTION 3. Section 462.025, Health and Safety Code, is | ||
amended by amending Subsections (a) and (e) and adding Subsection | ||
(b-1) to read as follows: | ||
(a) The commission shall adopt rules governing the | ||
voluntary admission of a patient to a treatment facility, including | ||
rules governing the intake, screening, and assessment procedures of | ||
the admission process. | ||
(b-1) The rules governing the screening process shall | ||
establish minimum standards for determining whether a prospective | ||
patient presents sufficient signs, symptoms, or behaviors | ||
indicating a potential chemical dependency disorder to warrant a | ||
more in-depth assessment by a qualified professional. The screening | ||
must be reviewed and approved by a qualified professional. | ||
(e) In accordance with commission rule, a treatment | ||
facility shall provide annually a minimum of two [ |
||
inservice training regarding intake and screening [ |
||
for persons who will be conducting an intake or screening [ |
||
|
||
screenings [ |
||
and applicable annual inservice training. | ||
SECTION 4. Section 462.025(h), Health and Safety Code, is | ||
amended by amending Subdivision (2) and adding Subdivision (4) to | ||
read as follows: | ||
(2) "Assessment" means the clinical [ |
||
process a treatment facility uses to gather information from a | ||
prospective patient, including a medical history and the problem | ||
for which the patient is seeking treatment, to determine whether a | ||
prospective patient should be admitted. | ||
(4) "Screening" means the process a treatment facility | ||
uses to determine whether a prospective patient presents sufficient | ||
signs, symptoms, or behaviors to warrant a more in-depth assessment | ||
by a qualified professional. | ||
SECTION 5. This Act takes effect September 1, 2011. |